<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01118390</url>
  </required_header>
  <id_info>
    <org_study_id>0072/09</org_study_id>
    <nct_id>NCT01118390</nct_id>
  </id_info>
  <brief_title>Treatment of Leg Telangiectasias With Nd:YAG 1064nm</brief_title>
  <official_title>Treatment of Leg Telangiectasias With Nd:YAG 1064nm</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Grupo de Cirurgia Vascular</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Grupo de Cirurgia Vascular</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Studying the results of treatment of dilated vessels of the lower limbs with laser, and
      compare them to those obtained with sclerotherapy.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Enrolling by invitation</last_known_status>
  <start_date>August 2009</start_date>
  <completion_date type="Anticipated">July 2010</completion_date>
  <primary_completion_date type="Actual">March 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>treatment of leg telangiectasias</measure>
    <time_frame>first day</time_frame>
    <description>Patients respond after treatment a questionnaire about satisfaction for both the laser and for conventional sclerotherapy.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Treatment of telangiectasias</measure>
    <time_frame>1 month</time_frame>
    <description>Patients respond after treatment a questionnaire about satisfaction for both the laser and for conventional sclerotherapy.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Presence of adverse effects</measure>
    <time_frame>after 1 month</time_frame>
    <description>Patients are monitored to adverse effects such as blemishes, scars and ulcers</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Scores on the Visual Analog Scale</measure>
    <time_frame>After 1 month</time_frame>
    <description>Patients evaluate pain on the Visual Analog Scale</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Telangiectasias</condition>
  <arm_group>
    <arm_group_label>Laser Nd:YAG 1064nm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with leg telangiectasias are treated with 3 sessions of Nd:YAG 1064nm, with 14 days interval</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sclerotherapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients with leg telangiectasias are treated with 3 sessions of sclerotherapy, with 14 days interval</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Laser Nd:YAG 1064nm</intervention_name>
    <description>Patients with leg telangiectasias are treated with 3 sessions of Nd:YAG 1064nm, with 14 days interval</description>
    <arm_group_label>Laser Nd:YAG 1064nm</arm_group_label>
    <other_name>laser</other_name>
    <other_name>Xeo</other_name>
    <other_name>Cool Glide</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sclerotherapy</intervention_name>
    <description>Patients with leg telangiectasias are treated with 3 sessions of sclerotherapy, with 14 days interval</description>
    <arm_group_label>Sclerotherapy</arm_group_label>
    <other_name>glicose</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with leg telangiectasias

        Exclusion Criteria:

          -  Arterial disease

          -  Varices

          -  Diabetes
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nelson Wolosker, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Hospital das Clinicas, University of Sao Paulo</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marco Munia, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital das Clinicas, University of Sao Paulo</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital das Clinicas da FMUSP</name>
      <address>
        <city>Sao Paulo</city>
        <zip>04534000</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <reference>
    <citation>Anderson RR, Parrish JA. Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science. 1983 Apr 29;220(4596):524-7.</citation>
    <PMID>6836297</PMID>
  </reference>
  <reference>
    <citation>Coles CM, Werner RS, Zelickson BD. Comparative pilot study evaluating the treatment of leg veins with a long pulse ND:YAG laser and sclerotherapy. Lasers Surg Med. 2002;30(2):154-9.</citation>
    <PMID>11870796</PMID>
  </reference>
  <reference>
    <citation>BÃ¤umler W, Ulrich H, Hartl A, Landthaler M, Shafirstein G. Optimal parameters for the treatment of leg veins using Nd:YAG lasers at 1064 nm. Br J Dermatol. 2006 Aug;155(2):364-71. Review.</citation>
    <PMID>16882176</PMID>
  </reference>
  <reference>
    <citation>Dudelzak J, Hussain M, Goldberg DJ. Vascular-specific laser wavelength for the treatment of facial telangiectasias. J Drugs Dermatol. 2009 Mar;8(3):227-9.</citation>
    <PMID>19271368</PMID>
  </reference>
  <verification_date>August 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 29, 2010</study_first_submitted>
  <study_first_submitted_qc>May 5, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 6, 2010</study_first_posted>
  <last_update_submitted>May 5, 2010</last_update_submitted>
  <last_update_submitted_qc>May 5, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 6, 2010</last_update_posted>
  <responsible_party>
    <name_title>Marco Antonio Munia</name_title>
    <organization>Departamento de Cirurgia Vascular HCFMUSP</organization>
  </responsible_party>
  <keyword>telangiectasias</keyword>
  <keyword>leg</keyword>
  <keyword>sclerotherapy</keyword>
  <keyword>laser</keyword>
  <keyword>glycose</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Telangiectasis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

